Patents by Inventor William Perrault

William Perrault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12180137
    Abstract: The present disclosure provides a crystalline form of enantiopure deuterium-enriched bupropion, pharmaceutical compositions, and methods of treating mood disorders, neurological disorders, movement disorders, cardiovascular disorders, metabolic disorders, and other disorders using a crystalline form of enantiopure deuterium-enriched bupropion.
    Type: Grant
    Filed: May 1, 2024
    Date of Patent: December 31, 2024
    Assignee: DeuteRx, LLC
    Inventors: Vincent Jacques, William Perrault